PsychoGenics
is a New Jersey-based preclinical CRO that offers services such as drug discovery and development for the pharmaceutical and life science industries... Read morePsychoGenics
is a New Jersey-based preclinical CRO that offers services such as drug discovery and development for the pharmaceutical and life science industries... Read more
News
Oct 09, 2024
Pharmaceutical Business Review
PsychoGenics: PsychoGenics secures NIH contract to identify new pain therapeutics
Aug 28, 2024
Benzinga
PsychoGenics: PsychoGenics Inc. Awarded $3 Million SBIR Grant to Employ Its AI-Enabled Platforms to Find Treatments for Rare Disorders
Dec 04, 2023
Pharmabiz
PsychoGenics: PsychoGenics inks pact with Roche to obtain global development, manufacturing, and commercialization rights to ENT1 Inhibitor, RO7117997 to treat neuropsychiatric disorders
Dec 01, 2023
StreetInsider
Press Release: PsychoGenics : PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor for the Treatment of Neuropsychiatric Disorders
Nov 10, 2023
StreetInsider
Press Release: PsychoGenics : PsychoGenics Launches an Updated Corporate Identity and Brand
Sep 05, 2023
Yahoo
PsychoGenics: PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant to use AI platforms to design new drugs for mental health disorders
Apr 09, 2023
Aithority
PsychoGenics: PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
Jan 12, 2023
BioSpace
PsychoGenics: IAMA Therapeutics and Psychogenics Sign a Preclinical Study Agreement for Dravet Syndrome
Oct 11, 2022
BioSpace
PsychoGenics: PsychoGenics Announces Extension of Ongoing Drug Discovery Collaboration with Karuna Therapeutics
Jul 25, 2022
BioSpace
PsychoGenics: IAMA Therapeutics Announces Initiation of Preclinical Development Studies in Drug-resistant Epilepsy Under a Service Agreement with Psychogenics
PsychoGenics Competitors
1
2
3
4
5
6
7
8
9
10